ADJUVANT CHEMOTHERAPY IN RESECTED NSCLC: TREATMENT FACTORS THAT IMPACT SURVIVAL OUTCOMES

被引:0
|
作者
Ramsden, K. [1 ]
Laskin, J. [1 ]
Ho, C. [1 ]
机构
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
76P
引用
收藏
页码:S31 / S32
页数:2
相关论文
共 50 条
  • [21] Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC
    Shen, Zi-Qing
    Feng, Kun-Peng
    Fang, Zi-Yao
    Xia, Tian
    Pan, Shu
    Ding, Cheng
    Xu, Chun
    Ju, Sheng
    Chen, Jun
    Li, Chang
    Zhao, Jun
    JOURNAL OF CARDIOTHORACIC SURGERY, 2024, 19 (01)
  • [22] Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC
    Zi-Qing Shen
    Kun-Peng Feng
    Zi-Yao Fang
    Tian Xia
    Shu Pan
    Cheng Ding
    Chun Xu
    Sheng Ju
    Jun Chen
    Chang Li
    Jun Zhao
    Journal of Cardiothoracic Surgery, 19
  • [23] Prognostic factors and impact of adjuvant radiotherapy and chemotherapy on resected mucinous adenocarcinomas of the pancreas
    Corsini, M. M.
    Miller, R. C.
    Haddock, M. G.
    Bhatia, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S293 - S293
  • [24] Postoperative Chemotherapy Use and Outcomes from ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR Mutated NSCLC
    Wu, Y.
    John, T.
    Grohe, C.
    Majem, M.
    Goldman, J.
    Kim, S.
    Kato, T.
    Laktionov, K. K.
    Vu, H. V.
    Wang, Z.
    Lu, S.
    Lee, K. Y.
    Akewanlop, C.
    Yu, C.
    De Marinis, F.
    Bonanno, L.
    Domine, M.
    Shepherd, F.
    Zeng, L.
    Atasoy, A.
    Herbst, R.
    Tsuboi, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S113 - S114
  • [25] Trends in Receipt of Adjuvant Chemotherapy and its Impact on Survival in Resected Biliary Tract Cancers
    Rhodin, Kristen E.
    Liu, Annie
    Bartholomew, Alex
    Kramer, Ryan
    Parameswaran, Anika
    Uronis, Hope
    Strickler, John
    Hsu, David
    Morse, Michael A.
    Shah, Kevin N.
    Herbert, Garth
    Zani, Sabino
    Nussbaum, Daniel P.
    Allen, Peter J.
    Lidsky, Michael E.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (8) : 4813 - 4821
  • [26] Trends in Receipt of Adjuvant Chemotherapy and its Impact on Survival in Resected Biliary Tract Cancers
    Kristen E. Rhodin
    Annie Liu
    Alex Bartholomew
    Ryan Kramer
    Anika Parameswaran
    Hope Uronis
    John Strickler
    David Hsu
    Michael A. Morse
    Kevin N. Shah
    Garth Herbert
    Sabino Zani
    Daniel P. Nussbaum
    Peter J. Allen
    Michael E. Lidsky
    Annals of Surgical Oncology, 2023, 30 : 4813 - 4821
  • [27] Time to the Initiation of Adjuvant Chemotherapy Does Not Impact Survival in Patients With Resected Pancreatic Cancer
    Mirkin, Katelin A.
    Greenleaf, Erin K.
    Hollenbeak, Christopher S.
    Wong, Joyce
    CANCER, 2016, 122 (19) : 2979 - 2987
  • [28] Survival impact of adjuvant chemotherapy for resected early-stage rectal adenocarcinoma.
    Tay, Rebecca Yin
    Jamnagerwalla, Murtaza
    Steel, Malcolm
    Wong, Hui-Li
    McKendrick, Joseph James
    Faragher, Ian
    Kosmider, Suzanne
    Hastie, Ian
    Desai, Jayesh
    Gibbs, Peter
    Wong, Rachel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [29] Effect of continuous adjuvant chemotherapy and protracted treatment on recurrence and survival in resected pancreatic adenocarcinoma
    Hashimoto, S.
    Oda, T.
    Yamada, K.
    Ohara, Y.
    Kobayashi, A.
    Fukunaga, K.
    Murata, S.
    Sasaki, R.
    Ohkohchi, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] Association between adjuvant component of perioperative chemotherapy and survival outcomes in resected gastric cancer (GC).
    Sreeram, Aravind
    Yeh, Celine
    Toumbacaris, Nicolas
    Capanu, Marinela
    Shimada, Shoji
    Gu, Ping
    Janjigian, Yelena Y.
    Ilson, David Herman
    Strong, Vivian E.
    Ku, Geoffrey Yuyat
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 378 - 378